Results 1 to 10 of about 7,148 (201)

Awareness of medication-overuse headache in Hail, Saudi Arabia [PDF]

Journal of Family Medicine and Primary Care
Background: Medication-overuse headache is a common neurological disorder that results in enormous disability and suffering, typically caused by the overuse of certain medications to relieve primary headaches.
Walid Alesefir, Sumayyah M. Almarshedy, Fahad Almarshadi, Luluh Z. Aljaloud, Alhanouf B. Alshammari, Turki T. Alshammari, Yousef H. Alanazi, Hailah A. Alanazi, Rasha A. Alrashidi   +8 more
doaj   +2 more sources

Neurobehavioral features in medication-overuse headache [PDF]

eNeurologicalSci
Background: Medication-overuse headache (MOH) has been related to the spectrum of dependence behavior and impaired orbitofrontal cortex function. Alexithymia is a trait comprising deficits in identifying self-emotions and perception.
Franz Riederer, Roberto Pirrotta, Chantal Martin Soelch, Andreas R. Gantenbein, Adrian Scutelnic, Antonia Klein, Christoph J. Schankin, Peter S. Sándor   +7 more
doaj   +2 more sources

Medication-Overuse Headache: Update on Management [PDF]

Life
Long-term frequent use of acute pain medication for the treatment of headaches has paradoxically been shown to increase the frequency of headaches. So-called medication-overuse headache (MOH) is particularly problematic in patients with migraine who ...
Prut Koonalintip, Katherine Phillips, Benjamin R. Wakerley   +2 more
doaj   +2 more sources

Evaluation of Risk Factors in Patients With Chronic Daily Headache and Medication‐Overuse Headache [PDF]

Brain and Behavior
Purpose The aim of this study is to compare the quality of life, daily physical activity level and perception of illness in patients with chronic daily headache, medication‐overuse headache, episodic migraine, and episodic tension‐type headache across ...
Gülcan Taşçatan, Hüseyin Tuğrul Atasoy, Esra Acıman Demirel, Vildan Çakır Kardeş, Mustafa Açıkgöz, Ulufer Çelebi, Bilge Piri Çınar, Bilgehan Açıkgöz, Aynur Özge   +8 more
doaj   +2 more sources

Medication-overuse headache: a narrative review [PDF]

The Journal of Headache and Pain
Medication-overuse headache (MOH), which potentially involves 1–2% of the population, is defined as a headache, on ≥ 15 days a month affected, along with overuse of one or other acute attack medications.
Helin Gosalia, David Moreno-Ajona, Peter J. Goadsby   +2 more
doaj   +2 more sources

The state of the art in treating patients with a dual diagnosis of chronic migraine and medication-overuse headache

Headache Medicine, 2023
Migraine is a common, highly prevalent genetic neurological disorder. Its most burdensome form is the chronic migraine, which is clinically defined by the presence of headache on ≥15 days/month for longer than three months, with eight or more typical ...
Carla Jevoux, Abouch Krymchantowski, Raimundo Pereira Silva-Néto, Ana Gabriela Krymchantowski, Ervin Michelstaedter Cotrik   +4 more
doaj   +1 more source

Management of medication overuse (MO) and medication overuse headache (MOH) S1 guideline

Neurological Research and Practice, 2022
Introduction Chronic headache due to the overuse of medication for the treatment of migraine attacks has a prevalence of 0.5–2.0%. This guideline provides guidance for the management of medication overuse (MO) and medication overuse headache (MOH ...
Hans-Christoph Diener, Peter Kropp, Thomas Dresler, Stefan Evers, Stefanie Förderreuther, Charly Gaul, Dagny Holle-Lee, Arne May, Uwe Niederberger, Sabrina Moll, Christoph Schankin, Christian Lampl   +11 more
doaj   +1 more source

Evaluation and treatment of medication-overuse headache: Russian experts’ guidelines

Неврология, нейропсихиатрия, психосоматика, 2022
The Russian experts’ guidelines on evaluation and treatment of medication-overuse headache are based on evidence-based medicine, the latest revision of the International Classification of Headache Disorders.
G. R. Tabeeva, V. V. Osipova, E. G. Filatova, Yu. E. Azimova, A. V. Amelin, A. R. Artyomenko, Yu. D. Vorobyeva, E. V. Ekusheva, M. I. Koreshkina, E. R. Lebedeva, N. V. Latysheva, M. V. Naprienko, A. V. Sergeev, K. V. Skorobogatykh, V. A. Golovacheva, A. P. Rachin, V. A. Parfenov   +16 more
doaj   +1 more source

Characteristics and comorbidities of headache in patients over 50 years of age: a cross-sectional study

BMC Geriatrics, 2022
Background Although headache is a common complaint in younger individuals, it is one of the most common complaints among persons over the age of 50 and is a significant cause of morbidity. As there are differences in the causes and types of headache, the
Mansoureh Togha, Mohammad Javad Karimitafti, Zeinab Ghorbani, Fatemeh Farham, Fereshteh Naderi-Behdani, Somayeh Nasergivehchi, Zahra Vahabi, Shadi Ariyanfar, Elham Jafari   +8 more
doaj   +1 more source

Predictors of response to erenumab after 12 months of treatment

Brain and Behavior, 2021
Objective Erenumab is a monoclonal antibody acting against calcitonin gene‐related peptide receptor and approved for the preventive treatment of chronic migraine.
Carlo Baraldi, Flavia Lo Castro, Maria Michela Cainazzo, Luca Pani, Simona Guerzoni   +4 more
doaj   +1 more source